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Weaned 3- to 4-month-old calves were fasted for 48 h, inoculated with 1010 CFU of Shiga toxin-positive
Escherichia coli (STEC) O157:H7 strain 86-24 (STEC O157) or STEC O91:H21 strain B2F1 (STEC O91), Shiga
toxin-negative E. coli O157:H7 strain 87-23 (Stx O157), or a nonpathogenic control E. coli strain, necropsied
4 days postinoculation, and examined bacteriologically and histologically. Some calves were treated with
dexamethasone (DEX) for 5 days (3 days before, on the day of, and 1 day after inoculation). STEC O157
bacteria were recovered from feces, intestines, or gall bladders of 74% (40/55) of calves 4 days after they were
inoculated with STEC O157. Colon and cecum were sites from which inoculum-type bacteria were most often
recovered. Histologic lesions of attaching-and-effacing (A/E) O157 bacteria were observed in 69% (38/55) of
the STEC O157-inoculated calves. Rectum, ileocecal valve, and distal colon were sites most likely to contain
A/E O157 bacteria. Fecal and intestinal levels of STEC O157 bacteria were significantly higher and A/E
O157 bacteria were more common in DEX-treated calves than in nontreated calves inoculated with STEC
O157. Fecal STEC O157 levels were significantly higher than Stx O157, STEC O91, or control E. coli; only
STEC O157 cells were recovered from tissues. Identifying the rectum, ileocecal valve, and distal colon as early
STEC O157 colonization sites and finding that DEX treatment enhances the susceptibility of weaned calves
to STEC O157 colonization will facilitate the identification and evaluation of interventions aimed at reducing
STEC O157 infection in cattle.
Enterohemorrhagic Escherichia coli bacteria are a subset of
Shiga toxin-producing E. coli (STEC) capable of causing hem-
orrhagic colitis (bloody diarrhea) and the hemolytic-uremic
syndrome in humans. All STEC strains produce one or more
Stx proteins (Stx1, Stx2, or a variant of Stx2). STEC O157:H7
(hereafter referred to as STEC O157) is the most frequently
reported STEC serotype associated with outbreaks of bloody
diarrhea and hemolytic-uremic syndrome in humans world-
wide (19, 24). Cattle are important sources of STEC O157.
STEC human pathogens are often foodborne, and most human
infections for which a source has been identified have been
attributed to the consumption of STEC O157-contaminated
bovine products or produce and/or water contaminated with
bovine manure. Healthy cattle transiently carry STEC sero-
types associated with disease in humans and intermittently
shed these bacteria into the environment in their feces. Many
STEC isolates from healthy cattle share common virulence
factors (i.e., Stx and intimin) with STEC that cause disease in
humans and with attaching-and-effacing (A/E) E. coli, enteric
pathogens that can cause diarrhea in young calves. Dysentery
has also been reported in neonatal calves naturally or experi-
mentally infected with non-O157 STEC (10, 31). Although not
considered bovine pathogens, STEC O157 strains cause severe
(sometimes fatal) diarrhea in experimentally inoculated neonatal
calves. STEC-infected colostrum-deprived and colostrum-fed
neonatal (36 h old) calves have high intestinal and fecal
levels of STEC O157 and characteristic lesions of bacterial
attachment and cytoplasmic effacement (A/E bacteria) in both
the large and small intestines (5, 7, 8).
The terminal rectum has been identified as the principal
STEC O157 colonization site in naturally and experimentally
infected cattle (14, 21, 22). Culturing rectoanal mucosal swab
samples is more sensitive than culturing feces for recovering
STEC O157 bacteria from naturally and experimentally in-
fected cattle (3, 13, 27).
Our long-term goal is to identify ways to reduce the presence
of STEC O157 in cattle in order to reduce food-borne infec-
tions in humans. We are using bovine STEC infection models
to locate early STEC colonization sites, to identify bacterial
and host factors that promote STEC O157 infections in cattle
(not necessarily the same as those involved in the pathogenesis
of disease in humans), and to evaluate interventions aimed at
reducing STEC O157 colonization and shedding in cattle. In
this article, we summarize our observations from multiple ex-
periments, involving 55 weaned calves inoculated with STEC
O157:H7 strain 86-24 and 9 control calves, performed to es-
tablish a reproducible bovine model of acute STEC O157 in-
fection and identify early STEC O157 colonization sites in
experimentally inoculated weaned calves (8, 25, 31; unpub-
lished observations). Initial efforts to establish a model in
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which weaned calves held off feed for 48 h were consistently
colonized with high levels of STEC O157 were hampered by
the large variations in the susceptibility of weaned calves to
experimental STEC infections. This prompted us to add high-
dose dexamethasone (DEX) treatment during the peri-inocu-
lation period to determine if exogenous DEX-induced immu-
nosuppression (a method for simulating physiologic stress that
enhances the susceptibility of cattle to a variety of bacterial,
viral, and protozoal diseases [1]) enhanced the susceptibility of
weaned calves to STEC O157 colonization infections (31). For
comparison, we also include observations from experiments
involving 14 weaned calves inoculated with Shiga toxin-nega-
tive E. coli O157 strain 87-23 (n 6) or STEC O91 strain B2F1
(n  8).
(A preliminary account of this report was presented at the
86th Annual Meeting of the Conference of Research Workers
in Animal Diseases, St. Louis, MO, 4 to 6 December 2005.)
MATERIALS AND METHODS
Bacterial strains and inocula. The E. coli bacterial strains used in these studies
are described in Table 1. STEC strains 86-24 (O157:H7), which produces Stx2
and intimin (9, 15), and B2F1 (O91:H21), which produces the activatable Shiga
toxin type 2d (16) but not intimin, are streptomycin-resistant mutants of the
original clinical isolates. E. coli O157:H7 strain 87-23 was isolated from the same
outbreak as strain 86-24 but lacks Stx1 and Stx2 genes. The E. coli control strain,
123, is resistant to nalidixic acid (9, 15). Stock inocula containing approximately
1010 CFU/ml were prepared and stored at 80°C as previously described (7).
Animals. Weaned calves of various breeds (including Jersey, Hereford, or
Hereford  Black Angus crosses), ranging in age from 3 to 5 months, were
housed in individual pens in an environmentally controlled facility at the Na-
tional Animal Disease Center (NADC) in Ames, IA, for at least 2 weeks prior to
inoculation and for the duration of the study. Calves were fed a diet of two-thirds
grain and one-third hay. To control intestinal nematodes, some of the calves were
treated with 1% Ivermectin (1 ml/100 lb) on the day of weaning and 21 to 28 days
after the initial treatment, and the cocciodiostat lasalocid was incorporated into
the feed. Animal care and all animal experiments were in accordance with the
requirements of the NADC Animal Care and Use Committee.
Animal treatments and inoculations. This report summarizes our observations
from a total of 78 weaned calves tested in 17 separate experiments (2 to 8
calves/experiment [Table 2]), some of which have been included in prior reports
(6, 8, 25, 31). To enhance their susceptibility to STEC O157 infection, all calves
were fasted for 48 h before they were inoculated and 35 calves inoculated with
STEC O157 (n  25), STEC O91 (n  4), E. coli Stx O157 (n  4), or the E.
coli control (n  2) were additionally treated with high-dose DEX (0.25 mg/kg
of body weight) by intravenous administration for 5 consecutive days (3 days
prior to inoculation, on the day of inoculation, and on the day after inoculation)
(1, 4). Peripheral venous blood samples were collected daily from 3 days before
the first DEX treatment until the end of the experiment for complete and
differential blood counts. Calves were inoculated intrarumenally or orally with
1010 CFU of STEC O157 (55 calves with Stx2 strain 86-24), Stx O157 (6 calves
with Stx strain 87-23), STEC O91 (8 calves with Stx 2d strain B2F1), or
nonpathogenic control E. coli strain (9 calves with control strain 123). All calves
were observed twice a day and necropsied at 4 days after inoculation. Fecal
samples were collected daily (0 to 4 days postinoculation [p.i.]) and frozen at
80°C for bacteriological culture. At necropsy, sections of tissues indicated in
Table 2 were collected aseptically and frozen at 80°C for bacteriological cul-
ture. Sections of intestinal tissues, gall bladders, kidneys, livers, and other pa-
renchymal tissues were collected for histopathologic examinations and immuno-
peroxidase staining (intestinal tissues and gall bladders only).
Histologic studies. Tissues were fixed in neutral buffered 10% formalin for 24
to 48 h, embedded in paraffin, sectioned, and stained with hematoxylin and eosin
for routine histology. Inoculum-type bacteria in formalin-fixed intestinal tissues
were identified by indirect immunoperoxidase staining (horseradish peroxidase)
with goat anti-O157:H7 (7) or by using rabbit anti-O91 or anti-O43 antibodies
(E. coli Reference Center, Pennsylvania State University, University Park) as the
primary antibody and biotinylated anti-goat or anti-rabbit antibodies (Vector
Laboratories, Inc., Burlingame, CA) as secondary antibodies (9).
Bacteriologic examination. At 4 to 7 days before inoculation, fecal samples
were obtained from all calves and screened for inoculum-type bacteria and
antibiotic-resistant normal flora by plating on selective media used for quanti-
tating the planned inoculum strain. The numbers of the inoculum-type bacteria
TABLE 1. E. coli strains used in this study
Strain (type) Serotype eaegene
Shiga toxin
gene Source
86-24 (STEC O157) O157:H7  stx2 P. Tarr (7, 15)
87-23a (Stx O157) O157:H7  None P. Tarr (2)
B2F1 (STEC O91) O91:H21  stx2d M. Karmali (12)
123 (control) O43:H28  None NADC (7, 18)
a Isolated from same outbreak as strain 86-24.
TABLE 2. Numbers of calves and tissues evaluated
E. coli inoculum
straina (type) Treatment
b
No. of calves
tested
(no. of
experiments)
No. of calves sampled for:
Bacteriologic studiesc Histologic studiesd
Feces Distalcolon Cecum Ileum
Gall
bladder Bile
Distal colon,
cecum, and
ileum
Ileocecal valve
and gall
bladder
Rectoanal
junction
86-24 (STEC O157) None 30 (10) 30 30 30 30 15 15 30 21 6
DEX 25 (5) 25 21 21 21 11 15 25 25 12
87-23 (Stx O157) None 2 (2) 1 2 1 1 2 2 2 2 2
DEX 4 (3) 4 0 0 0 0 4 4 4 4
B2F1 (STEC O91) None 4 (2) 4 4 4 4 4 4 4 4 4
DEX 4 (2) 4 4 4 4 4 4 4 4 4
123 (control) None 7 (2) 7 7 7 7 0 0 7 4 0
DEX 2 (1) 2 2 2 2 0 0 2 2 0
a As described in Table 1.
b Calves were treated with DEX, as described in Materials and Methods, or not treated. All calves were off feed for 48 h before they were inoculated intrarumenally
or orally with 1010 CFU of inoculum bacteria.
c Number of calves sampled at specified sites for bacteriologic studies. Fecal samples were collected daily (day 0 to 4 days p.i.), and tissue samples were collected
4 days after inoculation for bacteriological examination.
d Number of calves sampled at specified sites for histologic studies. Distal colon, cecum, and ileum tissues were collected from all of the calves; ileocecal valve, gall
bladder, and rectoanal junction tissues were also collected from some of the calves.
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recovered from tissues and feces of calves were quantitated on sorbitol MacCon-
key’s agar containing 100 g/ml streptomycin (strain 86-24), sorbitol MacCon-
key’s agar without antibiotics (strain 87-23), MacConkey’s agar containing 100
g/ml streptomycin (strain B2F1), or MacConkey’s agar containing 20 g/ml
nalidixic acid (strain 123). Total coliforms were quantitated on MacConkey agar
without antibiotics. To increase selectivity for strain 87-23, which lacked antibio-
tic selection, samples with high levels of enteric coliforms prior to inoculation
were also plated on sorbitol MacConkey’s agar supplemented with 2.5 g/ml
potassium tellurite (7). Selected sorbitol-negative isolates (strains 86-24 and
87-23) were tested for O157:H7 antigen by latex agglutination assay (7). Selected
coliforms were tested for O91 (strain B2F1) or O43 (strain 123) antigens by
colony blot immunoassay using appropriate O-specific sera (9). Gall bladder (1
to 2 g) and bile (5 to 10 ml) samples were also enriched in Trypticase soy broth
at 37°C before being cultured on appropriate media. For calculation of group
means, samples from which the inoculum-type bacteria were not recovered by
direct culture were assigned a value of 1,000 CFU of bacteria/g of sample (the
detection limit of the direct plating procedure).
Statistical analyses. The two-sided Fisher’s exact test was used to test the
significance of differences between the proportions of samples from DEX-
treated and nontreated calves from which inoculum bacteria were recovered or
in which A/E O157 bacteria were detected. The Mann-Whitney test and a
two-factor, unequal replication, repeated-measures analysis of variance were
used to determine the significance of differences between the numbers of bac-
teria recovered from DEX-treated and nontreated calves.
RESULTS
Effects of DEX treatment on blood and tissue leukocytes. All
DEX-treated calves exhibited hematologic profiles and histo-
logic lesions consistent with physiologic/corticosteroid stress
(1, 23). Beginning the first day following the first DEX treat-
ment and persisting until 3 to 4 days after inoculation, DEX-
treated calves’ leukograms were characterized by leukocytosis,
neutrophilia without left shift, lymphopenia, eosinopenia, and
occasionally monocytosis. There was moderate to marked lym-
phocyte depletion in the Peyer’s patches of DEX-treated
calves but not of nontreated calves.
Clinical observations and macroscopic lesions. Four DEX-
treated calves experienced watery diarrhea on days 3 and 4
(the feces of one calf contained blood on day 4), after they
were inoculated with STEC O157. All other calves remained
clinically healthy. The only significant gross lesion was edema
of the gall bladder serosa (31), which was seen in 12 of 25
DEX-treated calves inoculated with STEC O157.
Histologic observations. A/E O157 bacteria (i.e., intimately
attached bacteria associated with effacement of cytoplasm and
identified as E. coli O157 by immunohistochemistry) were ob-
served histologically in one or more tissues (rectoanal junction,
ileocecal valve, distal colon, cecum, ileum, or gall bladder)
from 38 of 55 calves inoculated with STEC O157 (Table 3 and
Fig. 1 and 2). At the rectoanal junction, O157 bacteria were
found attached not only to enterocytes but also to squamous
epithelial cells (Fig. 1). A/E O157 bacteria were not found in
the distal colon, cecum, ileum, or gall bladder or bile of any calf
that was shedding fewer than 105 CFU of inoculum-type STEC
O157 bacteria per g of feces at necropsy. However, A/E O157
bacteria were found in the rectoanal junction or ileocecal valve
of six nontreated and two DEX-treated STEC O157-inocu-
lated calves that were shedding 105 CFU of STEC O157
bacteria/g of feces.
As shown in Table 3, A/E O157 bacteria were found in a
higher proportion of DEX-treated calves than of nontreated
animals (92% versus 50% [P  0.01]) inoculated with STEC
O157. A/E O157 bacteria were found in significantly higher
proportions of distal colon, cecum, ileum, or gall bladder tis-
sues from DEX-treated animals compared to nontreated ani-
mals, and A/E O157 bacteria were not seen in ileum or gall
bladder samples from any nontreated calf (Table 3 and Fig. 2).
Rectoanal junction and ileocecal valve tissues were tissues in
which A/E O157 bacteria were most often found, and A/E
O157 bacteria were seen at these sites in similar proportions
of DEX-treated and nontreated calves. The rectoanal junction
was the only site in which A/E O157 bacteria were found in
4 of the DEX-treated calves; the ileocecal valve was the only
positive site in 11 of the nontreated calves.
A/E O157 bacteria were also found in the distal colon or
ileum (two of six calves) and in rectoanal junction or ileocecal
valve tissues (six of six calves) of weaned calves 4 days after
they were inoculated with E. coli Stx O157. No attached
TABLE 3. Recovery of STEC O157 bacteria and detection of A/E O157 bacteria in samples obtained from weaned calves 4 days after
inoculation with STEC O157:H7 strain 86-24
Type of result
No. of samples positive/no. tested (% positive) fora: P value for DEX
vs nontreatedbAll calves DEX-treated calves Nontreated Calves
Recovery of bacteria from:
Feces 40/54 (74) 24/25 (96) 16/29 (55) 0.01
Distal colon 24/51 (47) 15/21 (71) 9/30 (30) 0.01
Cecum 19/51 (37) 14/21 (67) 5/30 (17) 0.01
Ileum 7/48 (15) 6/21 (29) 1/27 (4) 0.04
Gall bladder 4/26 (15) 4/11 (36) 0/15 (0) 0.02
Detection of A/E O157 bacteria in:
Any site 38/55 (69) 23/25 (92) 15/30 (50) 0.001
Distal colon 22/55 (40) 18/25 (72) 4/30 (13) 0.01
Cecum 12/55 (22) 11/25 (44) 1/30 (3) 0.01
Ileum 5/55 (9) 5/25 (20) 0/30 (0) 0.02
Gall bladder 6/46 (13) 6/25 (24) 0/21 (0) 0.02
Ileocecal tissue 28/45 (62) 16/24 (67) 12/21 (57) 0.55
Rectoanal junction 15/18 (83) 11/12 (92) 4/6 (67) 0.25
a Number of samples from which STEC O157 bacteria were recovered or samples in which A/E O157 bacteria were detected by histology and immunohistochem-
istry.
b Two-sided P values by Fisher’s exact test.
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STEC O91 bacteria were found in any of the eight calves
inoculated with STEC O91, but A/E O157 bacteria were seen
in the rectoanal junctions of two of these calves which were
shedding STEC O157 bacteria in their feces before they
were inoculated with STEC O91 (see below). No A/E bac-
teria were seen in any of the nine calves inoculated with E.
coli control strain 123.
Recovery of inoculum-type bacteria. Bacterial culture results
are summarized in Table 3 and Fig. 2 and 4. Inoculum-type
bacteria were not recovered by direct culture from any of the
preinoculation fecal samples. However, rare STEC O157 inoc-
ulum-type bacteria (i.e., streptomycin-resistant, sorbitol-nega-
tive, O157 colonies) were recovered from the pre- and post-
inoculation fecal samples from two of the calves inoculated
with the STEC O91 strain B2F1, indicating that they were
shedding STEC O157 bacteria before they were inoculated
with STEC O91. As noted above, A/E O157 bacteria were
seen in the rectal tissue samples obtained from these two calves
at necropsy.
FIG. 3. Mean numbers of inoculum bacteria recovered from feces
(1 to 4 days p.i.) and tissues (4 days p.i.) from DEX-treated and
nontreated weaned calves inoculated intrarumenally or orally with 1010
CFU of STEC O157:H7 strain 86-24. For the calculation of mean
values for “all samples,” samples from which inoculum bacteria were
not recovered by direct plating were assigned a value of 1,000 CFU/g
of sample. For calculation of mean values for O157 samples, negative
results were excluded. Asterisks identify samples with significant dif-
ferences (P  0.05, Mann-Whitney test) between means for DEX-
treated and nontreated calves.
FIG. 1. STEC O157:H7 binding to rectal squamous and glandular epithelial cells in 4-month-old calves necropsied 4 days after inoculation with
STEC O157:H7 strain 86-24. (A and B) Overview of colorectal junction showing squamous epithelium (left) and columnar (glandular) epithelium
(right) (A) and immunoperoxidase-stained O157 bacteria attached to squamous epithelial cells (circles) and columnar epithelial cells
(squares) (B).
FIG. 2. Distribution of O157  A/E bacteria in tissues obtained
from DEX-treated and nontreated weaned calves at 4 days after in-
trarumenal or oral inoculation with STEC O157:H7 strain 86-24. Val-
ues correspond to the proportions of calves positive at any site and
proportions of specific tissues examined in which A/E O157 bacteria
were detected by histology and immunostaining with anti-O157:H7
antibodies. (See Table 2 for the numbers of calves and samples in each
group.)
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STEC O157 bacteria were recovered by direct culture from
the feces (74%), large or small intestinal tissues (47 and 15%,
respectively), or gall bladder tissues (15%) collected from
calves 4 days after they were inoculated with STEC O157.
These bacteria were recovered from higher proportions of the
tissues from DEX-treated calves than those from nontreated
calves (Table 3). STEC O157 inoculum-type bacteria were
recovered from 4 of 11 gall bladders and 3 of 15 bile samples
from DEX-treated calves, but not from gall bladder or bile
from any of the 15 nontreated calves sampled at these sites. As
shown in Fig. 3, the mean numbers of STEC O157 inoculum-
type bacteria recovered from feces (2 to 4 days p.i.) and intes-
tines (4 days pi) were significantly higher for all DEX-treated
calves (i.e., when negative samples were assigned a value of
1,000) compared to all similarly inoculated nontreated calves.
However, the only statistically significant difference between
the mean numbers of inoculum-type bacteria in the O157
samples (i.e., when mean values excluded negative results) in
DEX-treated and nontreated calves was the higher number of
STEC O157 bacteria in feces from DEX-treated calves at 2
days after inoculation.
The numbers of inoculum-type bacteria recovered from the
feces of calves inoculated with Stx O157, STEC O91, or
control strain 123 were consistently lower than the numbers
recovered from STEC O157-inoculated calves (Fig. 4). Be-
cause the group sizes for Stx O157-, STEC O91-, and control
strain 123-inoculated calves were small and treatment with
DEX did not appear to have much of an effect on the fecal
levels of these three inoculum types, the results for DEX-
treated and nontreated calves in each inoculum group were
combined for statistical comparisons with STEC O157. Signif-
icantly lower numbers of inoculum-type bacteria were recov-
ered from feces of calves at 1 to 4 days after inoculation with
STEC O91, at 3 and 4 days after inoculation with Stx O157
and at 2 and 3 days after inoculation with control strain 123,
compared to the numbers of inoculum-type bacteria recovered
from the feces of calves inoculated with STEC O157. None of
the fecal or tissue samples from any of the calves inoculated
with strains other than STEC O157 contained 104 CFU of
inoculum-type bacteria/g of sample at 4 days after inoculation.
The numbers of total fecal coliforms recovered from DEX-
treated and nontreated calves are shown in Fig. 4. No signifi-
cant differences were seen in the numbers of total fecal coli-
forms recovered from DEX-treated and nontreated calves on
day 0 (when DEX-treated calves had been treated with DEX
for 3 days and all calves had been off feed for 48 h) or at 1 to
3 days after inoculation. At 4 days after inoculation, the num-
bers of total coliforms were significantly higher for all DEX-
treated calves and for DEX-treated calves inoculated with
STEC O157 than those for the respective nontreated calves (P
0.05). STEC O157 bacteria accounted for 30% of the total
number of fecal coliforms recovered from DEX-treated calves
but only 5% of those from nontreated calves at 4 days after
inoculation.
DISCUSSION
Our findings provide important information about sites
where STEC O157:H7 bacteria colonize early (defined by the
presence of A/E bacteria or 104 CFU of inoculum-type bac-
teria/g of tissue at 4 days after inoculation) in experimentally
inoculated weaned calves. We showed that STEC O157 bac-
teria settle and cause characteristic A/E lesions in multiple
intestinal sites in weaned calves within 4 days after inoculation,
as they do in experimentally inoculated neonatal calves and
pigs (9) and other species (7, 20). We identified the rectum,
ileocecal valve, and distal colon as sites in calves most likely to
contain O157 A/E bacteria at 4 days after inoculation with
STEC O157 and the cecum, ileum, and gall bladder as other
sites where these bacteria were found. The most sensitive sites
for detecting STEC O157 colonization were the rectoanal junc-
tion and ileocecal valve: O157 A/E bacteria were found at
these sites in the greatest number of STEC O157-inoculated
calves and even in some calves that had 105 CFU of inocu-
lum/g of feces.
These results extend the evidence that the terminal rectum is
an important STEC O157:H7 colonization site in cattle (3, 14,
21). We detected A/E O157 bacteria in the rectoanal junction
of 83% of the calves necropsied 4 days after they were inocu-
lated with STEC O157. The rectoanal junction was the only
site where we found A/E O157 bacteria in the two calves
naturally infected with O157 bacteria before they were inocu-
lated. Our results show that the rectum is not only important as
a site where STEC O157 can persist in cattle but is also one of
the sites where STEC O157 initially attach and establish infec-
tions in cattle. Interestingly, in contrast to what Naylor found
in older cattle (21), we did not find STEC O157 bacteria
primarily associated with rectal or colonic lymphoid tissues in
these early infections in experimentally inoculated weaned
calves (results not shown).
We interpreted the presence of A/E O157 bacteria on the
rectoanal mucosa at 4 days following oral inoculation as evi-
dence that STEC O157 colonized the bovine rectoanal junc-
FIG. 4. Mean numbers of inoculum-type bacteria and total coli-
forms recovered from the feces of DEX-treated or nontreated calves 1
to 4 days after inoculation with STEC O157:H7 strain 86-24 (solid
lines) and mean numbers of inoculum bacteria from calves inoculated
with E. coli Stx O157:H7 strain 87-23, STEC O91:H21 strain B2F1, or
E. coli control strain 123 (broken lines). The mean numbers of total
coliforms for all DEX-treated and nontreated calves prior to inocula-
tion are indicated by open squares. Samples from which inoculum
bacteria were not recovered were assigned a value of 1,000 CFU/g of
sample for the calculation of mean values. Error bars represent 1
standard error of the mean.
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tion within the first few days after oral exposure. This argues
against the conclusion that recovery of inoculum bacteria from
bovine rectoanal mucosal swab samples in the first week after
experimental inoculation does not reflect rectal colonization,
but rather reflects wash through bacteria (28). Our results also
identify the ileocecal valve (62% of samples had A/E O157
bacteria) and distal colon (47% of samples were culture posi-
tive, and 40% had A/E O157 bacteria) as early STEC colo-
nization sites. Thus, the rectoanal junction, ileocecal valve, and
distal colon are early and sensitive colonization sites to mon-
itor when evaluating the efficacy of interventions aimed at
preventing STEC O157 infections in cattle.
Treatment of calves with DEX enhanced their susceptibility
to STEC O157 infection following experimental inoculation.
DEX-treated calves were more likely than nontreated calves to
be colonized at 4 days after they were inoculated with STEC
O157. The observation that the intestinal and fecal levels of
inoculum-type bacteria and the distribution of A/E O157
bacteria were similar in DEX-treated and nontreated calves
which were O157 (Fig. 2 and 3) indicates that the mecha-
nisms of STEC colonization in DEX-treated calves are similar
to those in nontreated calves and validates the use of DEX-
treated calves for STEC O157 studies. Treatment with DEX
did not increase the susceptibility of experimentally inoculated
weaned calves to colonization by Stx O157 or STEC O91.
Different bovine infection models will be needed to evaluate
colonization sites and mechanisms of non-O157 STEC.
DEX treatment was not selected because it mimics a specific
stress condition but because it has been widely used for en-
hancing infections with microorganisms and its immunosup-
pressive effects in cattle have been extensively investigated (1).
The specific mechanisms involved in DEX-induced enhance-
ment of susceptibility to STEC infections in cattle are outside
the scope of this article, but are the focus of ongoing experi-
ments (17).
The finding that intimin STEC O157 bacteria colonized
weaned calves better than intimin Stx O157 or intimin
STEC O91 bacteria extends the evidence that Stx and intimin
facilitate STEC O157 colonization in cattle (6, 11) but does not
rule out the possibility that other differences between these
nonisogenic strains also influence colonization. Stx facilitates
STEC O157:H7 colonization in orally or intrarumenally dosed
ruminant calves (see reference 11 and this study), but it does
not appear to influence intestinal colonization in intragastri-
cally dosed neonatal calves (6) or colonization of the terminal
rectal mucosa in steers inoculated intrarectally (29). In con-
trast, intimin is required for STEC O157:H7 colonization in
both neonatal and ruminant calves (6, 9) and for rectal colo-
nization after intrarectal inoculation of steers (29).
This study was not designed to evaluate effects of DEX on
fecal coliforms in cattle. Total fecal coliform counts were in-
cluded to allow comparisons of the levels of fecal coliforms in
DEX-treated and nontreated calves before they were inocu-
lated and comparisons of the numbers of inoculated strains
and total coliforms after inoculations. All of the calves were off
feed for 48 h before inoculation, and all were inoculated with
1010 CFU of one of the inoculum strains. Treatment of calves
with DEX for 3 days prior to inoculation had no apparent
effect on the numbers of total fecal coliforms at the time of
inoculation. However, coincident with higher numbers of
inoculum bacteria, DEX-treated calves had higher numbers
of total fecal coliforms than did nontreated calves at 4 days
after inoculation. The observation that the numbers of total
coliforms in nontreated calves were lower at 4 days after
inoculation than before inoculation extends the evidence
that stress due to feed restriction increases the fecal coli-
forms in cattle (4, 26).
The results of these studies extend the evidence that the
susceptibility of cattle to STEC infections is highly variable.
Only 55% of nontreated calves shed inoculum bacteria in their
feces or had A/E lesions at 4 days after inoculation with STEC
O157. Even the high-dose DEX treatments we used in these
studies, which increased the frequency and extent of STEC
O157 colonization in experimentally inoculated weaned calves,
did not result in all calves being equally susceptible to coloni-
zation after experimental inoculation with high levels of STEC
O157. These studies involved calves of different breeds from
different sources. Some of them were colostrum fed or co-
lostrum deprived and raised indoors. (The colostrum-deprived
calves were control calves available from earlier experiments;
we saw no apparent effects of colostrum deprivation on the
parameters we measured.) Some were raised with their dams
on pasture, and some were infected with coccidian parasites.
We carefully controlled the diets, housing, inocula and inocu-
lation procedures, necropsies, and sample collections. How-
ever, the selection of the sites which were sampled was an
experimental variable which changed over the course of the
experiments included in this study. In previous STEC bovine
infection studies at the NADC (5), the spiral colon was the
most distal intestinal site sampled. For our initial studies, we
extended sampling to include the distal colon. We began in-
cluding gall bladder and ileocecal valve samples when we
introduced DEX treatments. We added rectoanal junction
samples after this site was identified as a prominent STEC
colonization site in older cattle (21). The addition of ileocecal
valves and rectoanal junctions, which were highly sensitive sites
for detecting STEC O157, increased the numbers of animals
that were positive for A/E O157 bacteria. One can only spec-
ulate on whether inclusion of additional sampling sites, includ-
ing other sites that contain squamous epithelial cells, will fur-
ther increase the numbers of positive animals.
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